Evolent Health (EVH) FCF Margin (2015 - 2026)

Evolent Health's FCF Margin history runs 12 years deep, the most recent figure standing at 1.49% for Q1 2026.

• On a quarterly basis, FCF Margin fell 66.0% year-over-year to 1.49% in Q1 2026; TTM through Mar 2026 was 0.07%, a 48.0% increase from a year earlier, with the FY2025 full-year figure at 0.25%, up 49.0% from the prior year.
• FCF Margin declined to 1.49% in Q1 2026 per EVH's latest filing, from 8.76% in the prior quarter.
• Across five years, FCF Margin topped out at 14.99% in Q4 2023 and bottomed at 22.2% in Q1 2022.
• The 5-year median for FCF Margin is 0.07% (2024), against an average of 0.02%.
• Across the five-year window, FCF Margin slumped 2099 bps in 2022 and jumped 1822 bps in 2023, its largest moves.
• Year by year, FCF Margin stood at 6.52% in 2022, then jumped by 130 bps to 14.99% in 2023, then slumped by 133 bps to 5.01% in 2024, then soared by 275 bps to 8.76% in 2025, then tumbled by 117 bps to 1.49% in 2026.
• Per Business Quant, the three latest EVH FCF Margin figures stand at 1.49% (Q1 2026), 8.76% (Q4 2025), and 1.43% (Q3 2025).